A uniform approach to modeling risk factor relationships for ischemic lesion prevalence and extent: The women's health initiative magnetic resonance imaging study

Neuroepidemiology

Volumn 34, Issue 1, 2010, Pages 55-62

  Tooze, Janet A ^a   Gaussoin, Sarah A ^a   Resnick, Susan M ^b   Fischbein, Nancy J ^d   Robinson, Jennifer G ^e   Bryan, R Nick ^f   An, Yang ^c   Espeland, Mark A ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c MEDSTAR RESEARCH INSTITUTE   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain magnetic resonance imaging; Cognition; Statistical methods; Women's health

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; PLACEBO;

AGE; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL STUDY; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DOUBLE BLIND PROCEDURE; FEMALE; FRONTAL LOBE; HUMAN; HYPERTENSION; LIMBIC CORTEX; MAJOR CLINICAL STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL LOBE; PREVALENCE; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; TEMPORAL LOBE;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; RISK; RISK FACTORS; SMOKING;

EID: 70450193344     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000260071     Document Type: Article

References (32)

1. Bryan RN, Cai J, Burke G, Hutchinson RG, Liao D, Toole JF, Dagher AP, Cooper L: Prevalence and anatomic characteristics of infarct- like lesions on MR images of middleaged adults: the Atherosclerosis Risk in Communities Study. Am J Neuroradiol 1999; 20: 1273-1280.
2. Longstreth WT, Dulberg C, Manolio TA, Lewis MR, Beauchamp NJ Jr, O'Leary D, Carr J, Furberg CD: Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly. Stroke 2002; 33: 2376-2382.
3. Vermeer SE, Prins ND, Den Heijer T, Hofman A, Koudstall PJ, Breteler MMB: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-1222.
4. Vermeer SE, Hollande M, Van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MMB: Silent brain infarcts and white matter lesions increase stroke risk in the general population. Stroke 2003; 34: 1126-1129.
5. De Carli C, Massaro J, Harvey D, Hald J, Tullberg M, Au R, Beiser A, D'Agostino R, Wolf PA: Measures of brain morphology and infarction in the Framingham Heart Study: establishing what is normal. Neurobiol Aging 2005; 26: 491-510.
6. Schmidt R, Scheltens P, Erkinjuntti T, Pantoni L, Markus HS, Wallin A, Barkhof F, Fazekas F: White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology 2004; 63: 139-144.
7. Van Der Flier WM, Van Der Vlies AE, Weverling- Rijnsburger AWE, De Boer NL, Admiraal- Behloul F, Bollen EMEM, Westendorp RGJ, van Buchern MA, Middelkoop HAM: MRI measures and progression of cognitive decline in nondemented elderly attending a memory clinic. Int J Geriatr Psychiatry 2005; 20: 1060-1066.
8. Bisschops RHC, Klijn KJM, Kappelle LJ, Van Huffelen AC, Van Der Grond J: Prevalence and volume of internal border zone lesions in patients with impaired cerebral carbon dioxide vasomotor reactivity. Arch Neurol 2003; 60: 1233-1236.
9. Tooze JA, Grunwald GK, Rones RH: Analysis of repeated measures data with clumping at zero. Statist Meth Med Res 2002; 11: 341-355.
10. Tooze JA, Midthune D, Dodd KW, Freedman LS, Krebs-Smith SM, Subar AF, Guenther PM, Carroll RJ, Kipnis V: A new statistical method for estimating the usual intake of episodically consumed foods with application to their distribution. J Am Diet Assoc 2006; 106: 1575-1587.
11. The Women's Health Initiative Study Group: Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998; 19: 61-109.
12. Jaramillo SA, Felton D, Andrews L, Desiderio L, Hallarn RK, Jackson SD, Coker LH, Robinson JG, Ockene JK, Espeland MA: Enrollment in a brain magnetic resonance study: results from the Women's Health Initiative Memory Study Magnetic Resonance Imaging Study (WHIMS-MRI). Acad Radiol 2007; 14: 603-612.
13. Coker LH, Hogan PE, Bryan NR, Kuller LH, Margolis KL, Bettermann K, Wallace RB, Lao Z, Freeman R, Stefanick ML, Shumaker SA: Postmenopausal hormone therapy and subclinical cerebrovascular disease: The WHIMS-MRI Study. Neurology 2009; 72: 125-134.
14. Resnick SR, Espeland MA, Jaramillo SA, Hirsch C, Stefanick ML, Murray AM, Ockene J, Davatzikos C: Postmenopausal hormone therapy and regional brain volumes: The WHIMS-MRI Study. Neurology 2009; 72: 135-142.
15. Anbeek P, Vincken KL, Van Osch MJ, Bisschops RH, Van Der Grond J: Automatic segmentation of different-sized white matter lesions by voxel probability estimation. Med Image Anal 2004; 8: 205-215.
16. Yoshita M, Fletcher E, Harvey D, Ortega BS, Martinez O, Mungas DM, Reed BR, De Carli CS: Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology 2006; 67: 2192-2198.
17. Lao Z, Shen D, Liu D, Jawad AF, Melhem ER, Launder LJ, Bryan RN, Davatzikos C: Computer- assisted segmentation of white matter lesions in 3D MR images using support vector machine. Acad Radiol 2008; 15: 300-313.
18. Pantoni L, Garcia JH: Pathogenesis of leukoaraiosis: a review. Stroke 1997; 28: 652-659.
19. Moody DM, Bell MA, Challa VR: Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. Am J Neuroradiol 1990; 11: 431-439.
20. Teng EL, Chui HC: The Modified Mini- Mental State (3MS) examination. J Clin Psychiatry 1987; 48: 314-318.
21. Shumaker SA, Reboussin BA, Espeland MA, Rapp SR, McBee WL, Dailey M, Bowen D, Terrell T, Jones BN: The Women's Health Initiative Memory Study: a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 1998; 19: 604-621.
22. Resnick SM, Coker LH, Maki PM, Rapp SR, Espeland MA, Shumaker SA: The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials 2004; 1: 440-450.
23. Kuse AR: Familial Resemblances for Cognitive Abilities from Two Test Batteries in Hawaii; unpublished doctoral dissertation, University of Colorado, Boulder, 1977.
24. Benton A: Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968; 6: 53-60.
25. Newcombe F: Missile Wounds of the brain: a study of Psychological Deficits. London, Oxford University Press, 1969.
26. Benton AL: Revised Visual Retention Test. New York, Psychological Corporation, 1974.
27. Delis DC, Massman PJ, Kaplan E, McKee R, Kramer JH, Gettman D: Alternate form of the California Verbal Learning Test: development and reliability. Clin Neuropsychol 1991; 5: 154-162.
28. Wechsler D: Wechsler Adult Intelligence Scale - Revised. New York, Psychological Corporation, 1981.
29. Ekstrom RB, French JW, Harman HH: Manual for Kit of Factor-Referenced Cognitive Tests. Princeton, Educational Testing Service, 1976.
30. Halstead WC: Brain and Intelligence. Chicago, University of Chicago Press, 1947.
31. Basile AM, Pantoni L, Pracucci G, Asplund K, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D, LADIS Study Group: Age, hypertension and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS Study. Cerebrovasc Dis 2006; 21: 315-322.
32. Van Dijk EJ, Prins ND, Vrooman HA, Hoffman A, Koudstaal PJ, Breteler MMB: Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences. Stroke 2008; 39: 2712-2719.